Beyond the Balance Sheet: How a Nurse-Led Firm Is Remaking Mental Care

NEW YORK, NY – July 28, 2026 – In the high-stakes, venture-capital-fueled world of telehealth, company announcements often read like a scorecard of funding rounds and user acquisition metrics. But a recent press release from Lavender Psychiatry tells a different kind of story—one that finds its strength not in investor capital, but in clinical conviction. The company, now the largest nurse-owned telepsychiatry practice in the U.S., just marked two significant milestones: delivering its 300,000th patient appointment and the induction of its co-founder, Dr. Pritma Dhillon-Chattha, as a Fellow of the American Academy of Nursing (FAAN), one of the profession's highest honors.

These achievements are more than just corporate benchmarks; they are a powerful proof-of-concept for a quieter, more patient-centric revolution happening in mental healthcare. At a time when demand for services continues to catastrophically outpace supply, Lavender's journey from a bootstrapped startup to a national provider across 40 states offers a compelling alternative to the prevailing growth-at-all-costs narrative. It’s a story of what happens when clinicians, not financiers, sit at the head of the table.

A Different Kind of Growth Story

When Dr. Pritma Dhillon-Chattha and Dr. Brighid Gannon, two Yale-trained nurses, founded Lavender in May 2020, they were entering a telehealth market supercharged by the pandemic. Venture capital was pouring into digital health, with startups racing to scale. Yet, the co-founders chose a different path. They bootstrapped their company, a term that in the business world means relying on personal funds and revenue to grow, deliberately eschewing outside investment.

This decision is the central pillar of Lavender's identity. "When we started Lavender, we believed nurse practitioners could help reshape access to high-quality mental healthcare if they were given the opportunity to lead," stated Dr. Brighid Gannon, the company's Co-Founder. "Reaching more than 300,000 appointments while remaining entirely nurse-owned demonstrates that it's possible to build a healthcare organization around long-term patient outcomes and clinical excellence."

This clinician-first philosophy directly contrasts with the pressures faced by many VC-backed competitors, where the need to deliver rapid returns for investors can sometimes conflict with the long-term, often complex, needs of patient care. By remaining independent, Lavender has been able to make deliberate choices, such as investing heavily in its workforce of over 200 Psychiatric Mental Health Nurse Practitioners (PMHNPs). The company provides accredited continuing education, leadership training, and initiatives focused on preventing clinician burnout—investments that prioritize quality and sustainability over short-term profit margins.

While the company has avoided equity investment, its growth hasn't been without support. An early innovation grant from the American Nurses Association (ANA) provided crucial momentum. Public records also indicate a modest debt facility was secured in 2023, a common strategy for bootstrapped companies to fuel growth without ceding ownership or control. This disciplined financial strategy has allowed the organization to scale methodically while holding true to its founding principle: when clinicians guide healthcare decisions, patient care remains the primary focus.

The Power of the Nurse-Led Model

At the core of Lavender's success is its unwavering belief in the nurse-led care model. The practice is built around PMHNPs, highly trained advanced practice nurses who are licensed to diagnose, treat, and prescribe medication for mental health conditions. This model directly addresses one of the most significant barriers to care in the United States: a severe and worsening shortage of psychiatrists.

Academic research consistently validates the effectiveness of this approach. Studies show that nurse-led mental health interventions significantly improve patient well-being and that the quality of care provided by PMHNPs is comparable to that of psychiatrists. More importantly, nurses are trained in a holistic, "whole-person" philosophy. "Nurses have always understood that health is about more than symptoms; it's about understanding the whole person," said Dr. Dhillon-Chattha. This approach fosters trust and collaboration, which is critical in mental healthcare.

Lavender’s model integrates both psychiatry (medication management) and therapy, often delivered by the same clinician. This unified approach prevents the fragmented care many patients experience when juggling separate providers. The results speak for themselves: the company reports that approximately 86% of its clients see meaningful improvement in their mental health. While "meaningful improvement" is a proprietary metric, this figure stands up well against industry data. For example, some leading virtual care providers report patient response rates around 60% for depression, suggesting Lavender's integrated, nurse-led method is yielding strong clinical outcomes.

Operating a national telepsychiatry practice also requires navigating a complex web of state regulations. The scope of practice for nurse practitioners varies, with some states allowing full independence while others require physician collaboration. Telehealth has been a game-changer, allowing Lavender's clinicians in full-practice states to serve patients in underserved areas. Furthermore, the federal extension of pandemic-era rules through the end of 2026, which permit the remote prescription of certain controlled substances, has been crucial for ensuring continuity of care in telepsychiatry.

A New Era for Nursing Leadership

The second milestone—Dr. Dhillon-Chattha's induction as a Fellow of the American Academy of Nursing—is perhaps the most symbolic. The FAAN is an honor reserved for nursing's most accomplished leaders, with fewer than 1% of the nation's nursing faculty earning the distinction. It recognizes individuals who have made substantial and sustained contributions to advancing healthcare.

For Dr. Dhillon-Chattha, the honor is less a personal accolade and more a validation of her profession's potential. "Receiving a Fellowship in the American Academy of Nursing is an incredible honour, but I see it as recognition of something much larger than my own work," she explained. "It reflects what is possible when nursing leads innovation."

Her induction, alongside Lavender’s commercial success, signals a broader shift. For decades, nurses have been the backbone of the healthcare system, but their role in executive leadership and enterprise-level innovation has been historically undervalued. Lavender’s story is a powerful counter-narrative. It demonstrates that nurses are not just essential care providers but also astute entrepreneurs and systems-builders capable of creating scalable, sustainable, and effective healthcare solutions.

As the U.S. healthcare system continues to grapple with the monumental challenge of providing accessible and affordable mental healthcare, models like Lavender's offer more than just a service; they offer a new blueprint. By prioritizing clinical leadership and proving that sustainable growth can be achieved without sacrificing patient care for shareholder returns, the company is quietly challenging the status quo, one appointment at a time.